• Markets
    • icon
  • Companies
AHX · ASX

Apiam Animal Health Ltd. (ASX:AHX)

AU$0.28

 0.0 (0.0%)
ASX:Live
06/12/2023 04:10:05 PM
Hammer Bearish HALO Ords HALO Growth HALO Earnings Momentum HALO Consensus Value +4
Consensus Score
/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

AHX Overview

AHX Health Scores

Short Term

Mean Revision

Trend

Event

Halo Model

MQV

GARP

MQV Small

Valuation

Value

Consensus

Momentum

Price

Earnings

Growth

Earnings

Dividends

Quality

Capital Efficiency

Balance Sheet

About AHX

Website

Apiam Animal Health Ltd.

Telephone

61.3.5445.5999

Address

27-33 Piper Lane East Bendigo, Victoria (VIC) 3550

Description

Apiam Animal Health Ltd. engages in the provision of genetics, veterinary services, wholesale, and retail of related products. It operates through the following business segments: Dairy Mixed, Feedlots, and Pigs. The firm offers veterinary production, technology, genetics, warehousing, logistics, and wholesale services. The company was founded by Christopher Richards in 1998 and is headquartered in East Bendigo, Australia.

AHX Price Chart

Key Stats

Market Cap

AU$52.20M

PE

10.00

EV/EBITDA

0.0

Dividends Overview

DIV Yield

3.0%

Franking

100%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.23 - 0.68

Trade Value (12mth)

AU$10,917.00

1 week

-5%

1 month

9.62%

YTD

-55.47%

1 year

-57.46%

All time high

1.85053

Key Fundamentals

EPS 3 yr Growth

-63.600%

EBITDA Margin

8.90%

Operating Cashflow

$17m

Free Cash Flow Return

9.30%

ROIC

1.20%

Interest Coverage

4.50

Quick Ratio

0.60

Other Data

Shares on Issue (Fully Dilluted)

178m

HALO Sector

Healthcare

Next Company Report Date

26-Aug-24

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

AHX Announcements

Latest Announcements

Date Announcements

31 October 22

Change of Registry Address

×

Change of Registry Address

31 May 22

Presentation to the 20th Australasian AgFood Conference

×

Presentation to the 20th Australasian AgFood Conference

31 March 23

Release of shares from voluntary escrow

×

Release of shares from voluntary escrow

31 March 22

Release of shares from voluntary escrow

×

Release of shares from voluntary escrow

31 August 23

Release of shares from voluntary escrow

×

Release of shares from voluntary escrow

30 September 22

Board Renewal and key AGM dates

×

Board Renewal and key AGM dates

30 November 23

Apiam at Coffee Microcaps Morning Meeting Webinar Series

×

Apiam at Coffee Microcaps Morning Meeting Webinar Series

30 May 22

Entitlement Offer Update

×

Entitlement Offer Update

30 May 22

Retail Entitlement Offer Booklet

×

Retail Entitlement Offer Booklet

30 March 22

AHX secures viral vaccine lab funding

×

AHX secures viral vaccine lab funding

30 January 23

Strategic NSW acquisitions into two new high-growth regions

×

Strategic NSW acquisitions into two new high-growth regions

30 January 23

Proposed issue of securities - AHX

×

Proposed issue of securities - AHX

30 August 21

FY2021 Appendix 4E and Annual Report

×

FY2021 Appendix 4E and Annual Report

30 August 21

FY2021 Results Presentation

×

FY2021 Results Presentation

29 October 18

Notice of Annual General Meeting/Proxy Form

×

Notice of Annual General Meeting/Proxy Form

29 November 18

Managing Director's Presentation to Shareholders

×

Managing Director's Presentation to Shareholders

29 November 18

Results of 2018 Annual General Meeting

×

Results of 2018 Annual General Meeting

29 August 22

FY22 Appendix 4E and Annual Report

×

FY22 Appendix 4E and Annual Report

29 August 22

Dividend/Distribution - AHX

×

Dividend/Distribution - AHX

29 August 22

FY22 Results Release

×

FY22 Results Release

29 August 22

FY22 Investor Presentation

×

FY22 Investor Presentation

29 August 22

Appendix 4G and Corporate Governance Statement

×

Appendix 4G and Corporate Governance Statement

29 April 22

Investor Update

×

Investor Update

28 November 19

Managing Director's Presentation to Shareholders

×

Managing Director's Presentation to Shareholders

28 November 19

Results of 2019 Annual General Meeting

×

Results of 2019 Annual General Meeting

28 June 22

Change in substantial holding

×

Change in substantial holding

28 January 22

Application for quotation of securities - AHX

×

Application for quotation of securities - AHX

28 January 22

Issue of securities

×

Issue of securities

AHX Fundamentals

Per Share Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) $ Lock Lock Lock Lock 0.04 0.03 0.01 Lock Lock Lock
EPS (Fully Diluted) $ Lock Lock Lock Lock 0.04 0.03 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 15.1 -16.8 -62.0 Lock Lock Lock
     PE X Lock Lock Lock Lock 21.1 18.3 10.0 Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock 10.8 9.8 0.0 Lock Lock Lock
CFPS $ Lock Lock Lock Lock 0.09 0.08 0.09 Lock Lock Lock
FCFPS $ Lock Lock Lock Lock 0.06 0.06 0.05 Lock Lock Lock
     Growth % Lock Lock Lock Lock 11.7 -12.1 8.7 Lock Lock Lock
     Yield % Lock Lock Lock Lock 6.0 8.9 9.8 Lock Lock Lock
DPS $ Lock Lock Lock Lock 0.02 0.02 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock 20.0 -33.1 -100.0 Lock Lock Lock
     Yield % Lock Lock Lock Lock 2.1 2.4 3.0 Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock 57 46 0 Lock Lock Lock
BPS $ Lock Lock Lock Lock 0.60 0.65 0.66 Lock Lock Lock
BPS (Tangible) $ Lock Lock Lock Lock -0.12 -0.11 -0.26 Lock Lock Lock
     Growth % Lock Lock Lock Lock 20.6 6.4 -134.0 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 124 138 178 Lock Lock Lock
Basic m Lock Lock Lock Lock 122 136 175 Lock Lock Lock

Financial Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales $m Lock Lock Lock Lock 126 157 192 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.6 24.5 22.1 Lock Lock Lock
Selling & General Expenses $m Lock Lock Lock Lock 12 16 22 Lock Lock Lock
Gross Income $m Lock Lock Lock Lock 21 26 29 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.8 26.3 10.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 16.3 16.5 15.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock 84 83 85 Lock Lock Lock
EBITDA $m Lock Lock Lock Lock 15 18 17 Lock Lock Lock
     Growth % Lock Lock Lock Lock 6.7 22.6 -4.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock 11.6 11.4 8.9 Lock Lock Lock
Depreciation & Amortisation $m Lock Lock Lock Lock 6 8 10 Lock Lock Lock
EBIT $m Lock Lock Lock Lock 8 10 7 Lock Lock Lock
     Growth % Lock Lock Lock Lock 7.2 16.7 -28.1 Lock Lock Lock
     Margin % Lock Lock Lock Lock 6.5 6.1 3.6 Lock Lock Lock
Pretax Income $m Lock Lock Lock Lock 7 6 3 Lock Lock Lock
Income Taxes $m Lock Lock Lock Lock 2 2 1 Lock Lock Lock
Net Income $m Lock Lock Lock Lock 5 5 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 23.0 -7.9 -50.9 Lock Lock Lock
     Margin % Lock Lock Lock Lock 4.0 3.0 1.2 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow $m Lock Lock Lock Lock 14 15 17 Lock Lock Lock
Capital Expenditures $m Lock Lock Lock Lock 5 5 8 Lock Lock Lock
Net Investing Cash Flow $m Lock Lock Lock Lock -17 -32 -41 Lock Lock Lock
Net Financing Cash Flow $m Lock Lock Lock Lock 3 18 23 Lock Lock Lock
Free Cash Flow $m Lock Lock Lock Lock 9 11 10 Lock Lock Lock
     Growth % Lock Lock Lock Lock 52.7 20.2 -10.7 Lock Lock Lock
     Margin % Lock Lock Lock Lock 0.1 0.1 0.1 Lock Lock Lock
Franking Balance $m Lock Lock Lock Lock 10 11 13 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments $m Lock Lock Lock Lock 2 3 3 Lock Lock Lock
Total Assets $m Lock Lock Lock Lock 157 199 246 Lock Lock Lock
Long Term Debt $m Lock Lock Lock Lock 49 57 90 Lock Lock Lock
Net Debt $m Lock Lock Lock Lock 53 61 95 Lock Lock Lock
Total Liabilities $m Lock Lock Lock Lock 76 90 128 Lock Lock Lock
Equity $m Lock Lock Lock Lock 80 109 118 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 129 165 208 Lock Lock Lock
     Growth % Lock Lock Lock Lock 14.9 28.1 25.7 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock 3.2 2.3 0.9 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 6.3 4.3 1.9 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock 6.0 6.2 3.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock 3.9 3.1 1.2 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock 10.6 10.2 9.3 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

AUD 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock 12.4 11.4 4.5 Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 3.6 3.4 5.5 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock 66.3 55.8 80.5 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 1.4 1.2 1.0 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 0.7 0.6 0.6 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 6.5 7.9 9.1 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock 56.2 52.4 52.5 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 9.3 11.6 13.9 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock 6.6 7.8 9.8 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 14.1 22.1 130.7 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock 5.0 3.7 3.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.8 0.8 0.8 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.8 0.8 0.8 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock 5.5 4.1 1.6 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock 4.4 3.2 1.3 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock 29.3 30.3 32.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock 3.2 2.3 0.9 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 2.0 1.8 2.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock 6.3 4.3 1.9 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock 42.5 53.8 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock 2.7 2.3 1.9 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock 55.4 47.1 37.2 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock 39.1 31.6 26.2 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock 94.6 78.7 63.5 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 21.6 16.5 13.7 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock 73.0 62.2 49.8 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

3.0%

Franking Level

100%

DPSg

-100.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Expected Dividend Cashflow

Dividend Clarity,
Enhanced
Strategy

Upload your portfolio and gain access to 3-year dividend forecasts for each holding with HALO Global. Empower your decision-making and maximize returns with our advanced analytical tool. Try it today.

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

AHX Shortsell

Frequently Asked Questions

The current share price of Apiam Animal Health Ltd. (AHX:ASX) is AU$0.28.
The 52-week high share price for Apiam Animal Health Ltd. (AHX:ASX) is AU$0.68.
The 52-week low share price for Apiam Animal Health Ltd. (AHX:ASX)? is AU$0.23.
The current TTM dividend payout for Apiam Animal Health Ltd. (AHX:ASX) is 3.00.
The last dividend payment of Apiam Animal Health Ltd. (AHX:ASX) is AU$0.01.
Apiam Animal Health Ltd. (AHX:ASX) has a franking level of 100%.
Apiam Animal Health Ltd. (AHX:ASX) is classified in the Healthcare.
The current P/E ratio for Apiam Animal Health Ltd. (AHX:ASX) is 10.00.
halo-logo-inverted-rgb@72ppi-1
Login
Products
Company
Important

Get the latest insights and hot tips delivered right to your inbox

Apple Store
Google Play

HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.